Structural basis for postfusion-specific binding to Respiratory Syncytial Virus F protein by the canonical antigenic site I antibody 131-2a
Preprint
Abstract
The Respiratory Syncytial Virus (RSV) Fusion (F) protein is a major target of antiviral antibodies following natural infection or vaccination and responsible for mediating fusion between the viral envelope and the host membrane. The fusion process is driven by a large-scale conformational change in F, switching irreversibly from the metastable prefusion state to the stable postfusion conformation. Previous research has identified six distinct antigenic sites in RSV-F, termed sites Ø, I, II, III, IV, and V. Of these, only antigenic site I is fully specific to the postfusion conformation of F. A monoclonal antibody 131-2a that specifically targets postfusion F has been widely used as a research tool to probe for postfusion F and to define antigenic site I in serological studies, yet its sequence and precise epitope have remained unknown. Here we use mass spectrometry-based de novo sequencing of 131-2a to reverse engineer a recombinant product and study the epitope to define antigenic site I with molecular detail, revealing the structural basis for the antibody’s specificity towards postfusion RSV-F.Keywords
All Related Versions
- Published version: ACS Infectious Diseases, 11 (8), 2357.
This publication has 39 references indexed in Scilit:
- Rapid simulation of glycoprotein structures by grafting and steric exclusion of glycan conformer librariesCell, 2024
- Direct Mass Spectrometry-Based Detection and Antibody Sequencing of Monoclonal Gammopathy of Undetermined Significance from Patient Serum: A Case StudyJournal of Proteome Research, 2023
- Template-Based Assembly of Proteomic Short Reads For De Novo Antibody Sequencing and Repertoire ProfilingAnalytical Chemistry, 2022
- Deaths from RSV in young infants—the hidden community burdenThe Lancet Global Health, 2022
- Mass Spectrometry-Based De Novo Sequencing of Monoclonal Antibodies Using Multiple Proteases and a Dual Fragmentation SchemeJournal of Proteome Research, 2021
- Infants Infected with Respiratory Syncytial Virus Generate Potent Neutralizing Antibodies that Lack Somatic HypermutationImmunity, 2018
- Advances in RSV vaccine research and development – A global agendaVaccine, 2016
- The path to an RSV vaccineCurrent Opinion in Virology, 2013
- Inference of Macromolecular Assemblies from Crystalline StateJournal of Molecular Biology, 2007
- Mucosal vaccine delivery of antigens tightly bound to an adjuvant particle made from food-grade bacteriaMethods, 2006